Results suggest the FOXP3 positive immune infiltrate is increased in the advanced cSCC samples when compared to those in routine clinic samples, again correlated to the increased CFH observed in these advanced cSCC samples. The gene discussed is FOXP3; the disease is skin squamous cell carcinoma.